Surveillance of prescription drug-related mortality using death certificate data

Drug Safety

Volumn 30, Issue 6, 2007, Pages 533-540

  Wysowski, Diane K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CODEINE; HYPNOTIC AGENT; METHADONE; MORPHINE; NARCOTIC AGENT; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ACCIDENTAL DEATH; ANTICOAGULANT THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DATA ANALYSIS; DEATH CERTIFICATE; DRUG FATALITY; DRUG INTOXICATION; ENTEROCOLITIS; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; VITAL STATISTICS;

ANALGESICS, OPIOID; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE; DEATH CERTIFICATES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICATION ERRORS; OVERDOSE; PHARMACEUTICAL PREPARATIONS; POISONING; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 34249892158     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730060-00007     Document Type: Article

References (30)

1. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 2005; 165: 1363-9
2. International Statistical Classification of Diseases and Related Health Problems, Tenth revision, (ICD-10). Geneva: World Health Organization, 1992: volume 1
3. Public use data tape documentation. Multiple cause of death for ICD-10 1999-2003 data. Hyattsville (MD): U.S. Department of Health and Human Services, Public Health Service, National Center for Health Statistics, 1999-2003 [online]. Available from URL: http://wonder.cdc.gov/wonder/sci_data/mort/mcmort/ type_txt/mcmort03/ControlTotalTable1.pdf [Accessed 2007 Apr 27]
4. Pepin J, Valiquette L, Alary M-E, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1999 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-72
5. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-9
6. Bartlett JG, Perl TM. The new Clostridium difficile - what does it mean? N Engl J Med 2005; 353: 2503-5
7. Kaufman DW, Kelly JP, Levy M, et al. The drug etiology of agranulocytosis and aplastic anemia: monographs in epidemiology and biostatistics, volume 18. New York: Oxford University Press, 1991
8. Ibanez L, Vidal X, Laporte JR. Population-based drug-induced agranulocytosis. Arch Intern Med 2005; 165: 869-74
9. Shapiro S, Issaragrisil S, Kaufman DW, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 1999; 60: 573-7
10. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflamatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-63
11. Lassen A, Hallas J, de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006; 101: 945-53
12. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 264: 71-5
13. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004; 292: 2585-90
14. Cannon ML, Glazier SS, Bauman LA. Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg 2001; 95: 1053-6
15. Wysowski DK, Pollock ML. Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology 2006; 105: 1047-51
16. Wysowski DK, Nourjah P. Analyzing prescription drugs as causes of death on death certificates. Public Health Rep 2004; 119: 520
17. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-41
18. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine 2005; 84: 377-85
19. Sinert R, Kohl L, Rainone T, et al. Exercise-induced rhabdomyolysis. Ann Emerg Med 1994; 23: 1301-6
20. Wysowski DK, Governale LA, Swann J. Trends in outpatient prescription drug use and related costs in the US. Pharmacoeconomics 2006; 24: 233-6
21. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 618-27
22. Cicero TJ, Inciardi JA. Diversion and abuse of methadone prescribed for pain management. JAMA 2005; 293: 297-8
23. Dart RC, Woody GE, Kleber HD. Prescribing methadone as an analgesic. Ann Intern Med 2005; 143: 620
24. Mueller MR, Shah NG, Landen MG. Unintentional prescription drug overdose deaths in New Mexico, 1994-2003. Am J Prev Med 2006; 30: 423-9
25. Cone EJ, Fant RV, Rohay JM, et al. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol 2003; 27: 57-67
26. Fingerhut LA. Increase in methadone-related deaths: 1999-2004 [online]. Available from URL: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ methadone1999-04/methadone1999-04.htm [Accessed 2007 May 7]
27. Tharp AM, Winecker RE, Winston DC. Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches. Am J Forensic Med Pathol 2004; 25: 178-81
28. Barrueto F Jr, Howland MA, Hoffman RS. The fentanyl tea bag. Vet Hum Toxicol 2004; 46: 30-1
29. Meadows M. Proper use of fentanyl pain patches. FDA Consumer magazine March-April, 2006
30. Wysowski DK. Increase in deaths related to enterocolitis due to Clostridium difficle in the United States, 1999-2002. Public Health Rep 2006; 121: 361-2